12/10/09

NIMS’ Exer-Rest® Technology Presented at American Heart Association Symposium

12/03/09

NIMS Receives Canadian Patent for Its Exer-Rest® Platform

11/19/09

NIMS Receives Japanese Patent for Its Exer-Rest® Platform

09/14/09

Exer-Rest Technology Presentation at the 2009 European Society of Cardiology Congress is Highly Effective in Treatment of Patients with Coronary Artery Disease, Angina and Reduced Cardiac Function

04/01/09

NIMS Exer-Rest® Technology Linked to Reduced Brain Damage in Strokes

02/02/09

NIMS Announces FDA Approval to Market Its Flagship Product Exer-Rest®

11/12/08

NIMS' Acceleration Platform Technology: An Effective Non-Invasive Strategy For Cardiac Protection

11/03/08

NIMS Elects Dr. Jane H. Hsiao Chairman of the Board

09/04/08

NIMS' Acceleration Therapeutic Platform: Potential Non-Invasive Home Treatment of Coronary Artery Disease

07/31/08

Non-Invasive Monitoring Systems, Inc. (NIMS) Announces Patent on Additional Applications for its Acceleration Therapeutics Technology

06/02/08

NIMS' Exer-Rest® Acceleration Platform to be Launched at Physical and Rehabilitation Congress

05/27/08

NIMS' Acceleration Platform Technology Effective in Severe Experimental Hemorrhagic Shock

05/05/08

NIMS' Acceleration Platform to be Investigated as a New Treatment of Cardiovascular Disease

04/07/08

Non-Invasive Monitoring Systems, Inc. Receives Additional Financing

03/27/08

Non-Invasive Monitoring Systems, Inc. Announces Temporary Change in Ticker Symbol

01/28/08

NIMS, The Pioneer In Acceleration Therapeutics Platforms, Receives ISO Certification and Medical Device CE0120 Approval.

01/24/08

NIMS' Motion Platform Treatments Potentially Decrease Cardiovascular Risk in Unfit Subjects.

12/04/07

NIMS' Motion Platform Treatments Beneficial in Patients with Heart Failure and Peripheral Arterial Disease.

11/15/07

NIMS' Motion Platform Pre- and Post-Treatments Beneficial in Experimental Cardiac Arrest.

10/04/07

Non-Invasive Monitoring Systems, Inc. (NIMS) Enters into Agreement with SingLin Technology, Ltd. for Development and Supply of Exer-Rest(TM) and "Somno-Ease" to NIMS.

06/12/07

Non-Invasive Monitoring Systems, Inc. (NIMS) Announces Patent Issued on Non-Invasive Means to Treat Ailments in Horses.

05/01/07

Non-Invasive Monitoring Systems, Inc. (NIMS) Announces that it's Chairman has Received Honorary Doctorate Degree.

04/17/07

Non-Invasive Monitoring Systems, Inc. (NIMS) Announces European Patent Issued for its Motion Platform Technology.

01/16/07

Non-Invasive Monitoring Systems, Inc. Announces Appointment of Gary Wetstein as Chief Financial Officer.

12/06/06

Non-Invasive Monitoring Systems, Inc. Notified That Its Motion Platform Has Met Requirements of Medical Device Directive for European Union.

12/04/06

Review of Non-Invasive Monitoring Systems, Inc. Motion Platform Device Published in Wolf Creek Conference on Cardiopulmonary Resuscitation.

11/15/06

NIMS' CPR Motion Platform Device Papers Presented at American Heart Association Meeting.

10/20/06

Non Invasive Monitoring Systems, Inc. Receives Additional Financing.

10/19/06

Non-Invasive Monitoring Systems, Inc. (NIMS) Announces Patent on Multiple Applications for its Motion Platform Technology.

09/06/06

NIMS' Modified AT-101(TM) Motion Platform Device Superior to Mechanical Closed Chest Message Device in CPR.

08/17/06

Non-Invasive Monitoring Systems, Inc. (NIMS) Announces Grant of Patent on Non-Invasive Means to Stimulate Release of Beneficial Mediators from Inner Lining of Blood Vessels.

07/24/06

Non-Invasive Monitoring Systems, Inc. Announces Effectiveness of Their Patented, Non-Invasive, Drug-Free Device in Experimental Asthma.

04/26/06

Non Invasive Monitoring Systems, Inc. NIMS Receives Notice of Allowance from US Patent Office.

03/29/06

Non-Invasive Monitoring Systems, Inc. (NIMS)(NIMU.OB) Receives Notices of Patent Allowances from US and European Offices.

01/10/06

Non-Invasive Monitoring Systems Awarded SBIR Phase 1 Contract for Non-Invasive Monitoring of Cardiac Output by U.S. Army.

11/10/05

NIMS Receives Capital Financing to Continue Operations and Re-Build Company Infrastructure.

08/23/05

NIMS Closes an Aggregate of $1,000,000 Financing and Appoints Chief Executive Officer.

01/18/05

Acceleration Therapeutics' AT-101 Device Provides Beneficial Effect of Vasodilatation in Published Study.

12/07/04

Study of Acceleration Therapeutics' AT-101 Reveals for the First Time That Nitric Oxide is Released Into the Human Bloodstream.

11/17/04

Acceleration Therapeutics' AT-101 Used Successfully in Experimental CPR to Prove Cardio protective Effect.

09/21/04

Acceleration Therapeutics' AT-101 Device Shows Usefulness in Experimental Asthma and CPR.

Acceleration Therapeutics' AT-101 Provides Symptomatic Relief in Fibromyalgia & Chronic Fatigue Syndrome.

September 08, 2010
Loading...
Delayed 20 Mins